Study team
Dr Ian Anderson
Dr Anderson heads up the REMEDi study. He is a senior lecturer and honorary consultant psychiatrist. He is Director of the Specialist Service for Affective Disorders which is tertiary service for difficult-to-treat mood disorders based at Manchester Royal Infirmary. He has had a long-term research interest in how antidepressants work in the brain and is internationally recognised for developing evidence-based guidelines on the treatment of depression.
Dr Danilo Arnone
Dr Arnone is the clinical research fellow on the REMEDi study. He is a Specialist Registrar in Psychiatry with the Oxford Deanery, currently undergoing his PhD program in Manchester with Dr Anderson.
Emma Pegg
Emma is a research assistant on the REMEDi study. She studied psychology at the University of Sheffield, and is now close to completing a PhD investigating rumination, cognition and depression with fMRI.
Professor Bill Deakin
Professor Deakin is the Director of the Neuroscience and Psychiatry Unit and Professor of Psychiatry at Manchester University. In recent years his group has developed ways of imaging 5HT and glutamate functioning in the living human brain using magnetic resonance imaging and investigating their role in basic motivational processes of reward and punishment. He heads a large EU consortium called New Molecules for Mood Disorders (www.newmood.co.uk) which aims to find new genetic & biochemical mechanisms of depression, and recently completed a MRC Programme grant which is investigating brain mechanisms of impulsiveness and disorders of social behaviour in prisoners and anxious individuals.
Dr Rebecca Elliott
Dr Rebecca Elliott is a senior research fellow with a PhD in cognitive neuropsychology. She has worked in neuroimaging for 10 years and is interested in understanding the brain basis of motivation and emotion, particularly in people with mood disorders.
Dr Shane McKie
Dr Shane McKie (PhD MSc MEng) is a Research Fellow in Psychopharmacological Imaging and has been with the NPU since early 2002. His current research interests include pharmacoMRI (phMRI), fMRI task design and analysis, and functional/effective connectivity. He also works around the University investigating obesity, mild cognitive impairment, Parkinson’s Disease and dermatology.
